Moreover, the most prevalent rheumatologic manifestations in the non-GATA2 mutated MDS group are vasculitis, namely polyarteritis nodosa and giant-cell arteritis, differently from GATA2 mutated patients (39, 40). Here, GATA2 is linked to vasculitis.